StockNews.com cut shares of Pearson (NYSE:PSO – Free Report) from a buy rating to a hold rating in a report published on Friday.
Separately, Citigroup raised Pearson to a “strong-buy” rating in a research report on Tuesday, July 30th.
View Our Latest Stock Report on PSO
Pearson Trading Down 0.5 %
Hedge Funds Weigh In On Pearson
A number of hedge funds have recently bought and sold shares of PSO. EverSource Wealth Advisors LLC lifted its holdings in Pearson by 88.7% during the 1st quarter. EverSource Wealth Advisors LLC now owns 2,421 shares of the company’s stock worth $29,000 after buying an additional 1,138 shares during the last quarter. GAMMA Investing LLC lifted its stake in Pearson by 43.2% during the second quarter. GAMMA Investing LLC now owns 2,782 shares of the company’s stock worth $35,000 after purchasing an additional 839 shares during the last quarter. SageView Advisory Group LLC acquired a new position in shares of Pearson in the 1st quarter valued at about $42,000. Allspring Global Investments Holdings LLC raised its stake in Pearson by 86.9% during the third quarter. Allspring Global Investments Holdings LLC now owns 3,145 shares of the company’s stock worth $43,000 after acquiring an additional 1,462 shares during the period. Finally, CWM LLC lifted its holdings in Pearson by 22.5% in the second quarter. CWM LLC now owns 4,650 shares of the company’s stock worth $58,000 after acquiring an additional 855 shares during the last quarter. 2.14% of the stock is currently owned by institutional investors and hedge funds.
Pearson Company Profile
Pearson plc offers educational courseware, assessments, and services in the United Kingdom, the United States, Canada, the Asia Pacific, other European countries, and internationally. The company operates through five segments: Assessment & Qualifications, Virtual Learning, English Language Learning, Workforce Skills, and Higher Education.
Recommended Stories
- Five stocks we like better than Pearson
- What Do S&P 500 Stocks Tell Investors About the Market?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Top Biotech Stocks: Exploring Innovation Opportunities
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Quiet Period Expirations Explained
- Time to Load Up on Home Builders?
Receive News & Ratings for Pearson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pearson and related companies with MarketBeat.com's FREE daily email newsletter.